Sign In

Login

Password

Forgot Password ? Sign Up

Simeprevir (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Simeprevir" in Czech language version.

refsWebsite
Global rank Czech rank
5doi.org
2nd place
4th place
3worldcat.org
5th place
3rd place
3nih.gov
4th place
8th place
1dovepress.com
low place
low place
1wiley.com
222nd place
83rd place
1e-cmh.org
low place
low place
1elsevier.com
610th place
203rd place
1asm.org
3,555th place
1,232nd place

asm.org

journals.asm.org

  • BOURGEOIS, Stefan; HORSMANS, Yves; NEVENS, Frederik. Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen. Antimicrobial Agents and Chemotherapy. 2017-12, roč. 61, čís. 12, s. e01217–17. Dostupné online [cit. 2023-01-31]. ISSN 0066-4804. doi:10.1128/AAC.01217-17. PMID 28971875. (anglicky) 

doi.org

  • BROCHOT, Etienne; IZQUIERDO, Laure; CASTELAIN, Sandrine. Simeprevir for the treatment of hepatitis C virus infection. Pharmacogenomics and Personalized Medicine. 2014-08, s. 241. Dostupné online [cit. 2023-01-31]. ISSN 1178-7066. doi:10.2147/PGPM.S52715. PMID 25206310. (anglicky) 
  • MAJUMDAR, A.; KITSON, M. T.; ROBERTS, S. K. Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis. Alimentary Pharmacology & Therapeutics. 2016-06, roč. 43, čís. 12, s. 1276–1292. Dostupné online [cit. 2023-01-31]. doi:10.1111/apt.13633. (anglicky) 
  • KIM, Chang Wook; CHANG, Kyong-Mi. Hepatitis C virus: virology and life cycle. Clinical and Molecular Hepatology. 2013, roč. 19, čís. 1, s. 17. Dostupné online [cit. 2023-01-31]. ISSN 2287-2728. doi:10.3350/cmh.2013.19.1.17. PMID 23593605. (anglicky) 
  • REESINK, Henk W.; FANNING, Gregory C.; FARHA, Khalid Abou. Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients. Gastroenterology. 2010-03, roč. 138, čís. 3, s. 913–921. Dostupné online [cit. 2023-01-31]. doi:10.1053/j.gastro.2009.10.033. (anglicky) 
  • BOURGEOIS, Stefan; HORSMANS, Yves; NEVENS, Frederik. Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen. Antimicrobial Agents and Chemotherapy. 2017-12, roč. 61, čís. 12, s. e01217–17. Dostupné online [cit. 2023-01-31]. ISSN 0066-4804. doi:10.1128/AAC.01217-17. PMID 28971875. (anglicky) 

dovepress.com

e-cmh.org

elsevier.com

linkinghub.elsevier.com

  • REESINK, Henk W.; FANNING, Gregory C.; FARHA, Khalid Abou. Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients. Gastroenterology. 2010-03, roč. 138, čís. 3, s. 913–921. Dostupné online [cit. 2023-01-31]. doi:10.1053/j.gastro.2009.10.033. (anglicky) 

nih.gov

ncbi.nlm.nih.gov

  • BROCHOT, Etienne; IZQUIERDO, Laure; CASTELAIN, Sandrine. Simeprevir for the treatment of hepatitis C virus infection. Pharmacogenomics and Personalized Medicine. 2014-08, s. 241. Dostupné online [cit. 2023-01-31]. ISSN 1178-7066. doi:10.2147/PGPM.S52715. PMID 25206310. (anglicky) 
  • KIM, Chang Wook; CHANG, Kyong-Mi. Hepatitis C virus: virology and life cycle. Clinical and Molecular Hepatology. 2013, roč. 19, čís. 1, s. 17. Dostupné online [cit. 2023-01-31]. ISSN 2287-2728. doi:10.3350/cmh.2013.19.1.17. PMID 23593605. (anglicky) 
  • BOURGEOIS, Stefan; HORSMANS, Yves; NEVENS, Frederik. Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen. Antimicrobial Agents and Chemotherapy. 2017-12, roč. 61, čís. 12, s. e01217–17. Dostupné online [cit. 2023-01-31]. ISSN 0066-4804. doi:10.1128/AAC.01217-17. PMID 28971875. (anglicky) 

wiley.com

onlinelibrary.wiley.com

  • MAJUMDAR, A.; KITSON, M. T.; ROBERTS, S. K. Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis. Alimentary Pharmacology & Therapeutics. 2016-06, roč. 43, čís. 12, s. 1276–1292. Dostupné online [cit. 2023-01-31]. doi:10.1111/apt.13633. (anglicky) 

worldcat.org

  • BROCHOT, Etienne; IZQUIERDO, Laure; CASTELAIN, Sandrine. Simeprevir for the treatment of hepatitis C virus infection. Pharmacogenomics and Personalized Medicine. 2014-08, s. 241. Dostupné online [cit. 2023-01-31]. ISSN 1178-7066. doi:10.2147/PGPM.S52715. PMID 25206310. (anglicky) 
  • KIM, Chang Wook; CHANG, Kyong-Mi. Hepatitis C virus: virology and life cycle. Clinical and Molecular Hepatology. 2013, roč. 19, čís. 1, s. 17. Dostupné online [cit. 2023-01-31]. ISSN 2287-2728. doi:10.3350/cmh.2013.19.1.17. PMID 23593605. (anglicky) 
  • BOURGEOIS, Stefan; HORSMANS, Yves; NEVENS, Frederik. Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen. Antimicrobial Agents and Chemotherapy. 2017-12, roč. 61, čís. 12, s. e01217–17. Dostupné online [cit. 2023-01-31]. ISSN 0066-4804. doi:10.1128/AAC.01217-17. PMID 28971875. (anglicky)